NEUSERINE

Welcome to the Brand page for “NEUSERINE”, which is offered here for Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical preparations for pharmaceutical or medical purposes, for treating neuropsychiatric disorders, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; chemical reagents for medical or veterinary purposes, excluding reagents for use in development of skin care products or cosmetics; antibacterial substances for medical purposes, excluding antibacterial substances for use in skin care products or cosmetics; amino acid preparations for medical purposes, excluding amino acid preparations for use in skin care products or cosmetics; amino acids for medical or veterinary purposes, excluding amino acids for use in skin care products or cosmetics; amino acids for medical purposes, excluding amino acids for use in skin care products or cosmetics;.

Its status is currently believed to be active. Its class is unavailable. “NEUSERINE” is believed to be currently owned by “SyneuRx International (Taiwan) Corp”.